HomeComparePNTZF vs JNJ

PNTZF vs JNJ: Dividend Comparison 2026

PNTZF yields 747.38% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PNTZF wins by $1566096.58M in total portfolio value
10 years
PNTZF
PNTZF
● Live price
747.38%
Share price
$0.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1566096.61M
Annual income
$1,239,780,398,790.85
Full PNTZF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PNTZF vs JNJ

📍 PNTZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPNTZFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PNTZF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PNTZF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PNTZF
Annual income on $10K today (after 15% tax)
$63,527.65/yr
After 10yr DRIP, annual income (after tax)
$1,053,813,338,972.22/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, PNTZF beats the other by $1,053,813,334,986.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PNTZF + JNJ for your $10,000?

PNTZF: 50%JNJ: 50%
100% JNJ50/50100% PNTZF
Portfolio after 10yr
$783048.32M
Annual income
$619,890,201,740.12/yr
Blended yield
79.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PNTZF
No analyst data
Altman Z
-2.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PNTZF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPNTZFJNJ
Forward yield747.38%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1566096.61M$30.3K
Annual income after 10y$1,239,780,398,790.85$4,689.40
Total dividends collected$1539987.36M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PNTZF vs JNJ ($10,000, DRIP)

YearPNTZF PortfolioPNTZF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$85,438$74,738.42$10,592$272.30+$74.8KPNTZF
2$688,198$596,778.67$11,289$357.73+$676.9KPNTZF
3$5,228,887$4,492,515.64$12,123$472.89+$5.22MPNTZF
4$37,495,728$31,900,818.89$13,141$629.86+$37.48MPNTZF
5$253,911,995$213,791,566.18$14,408$846.81+$253.90MPNTZF
6$1,624,718,298$1,353,032,462.86$16,021$1,151.60+$1624.70MPNTZF
7$9,829,766,992$8,091,318,413.54$18,122$1,588.22+$9829.75MPNTZF
8$56,268,858,584$45,751,007,901.87$20,930$2,228.20+$56268.84MPNTZF
9$304,968,426,063$244,760,747,378.05$24,792$3,191.91+$304968.40MPNTZF
10$1,566,096,614,678$1,239,780,398,790.85$30,274$4,689.40+$1566096.58MPNTZF

PNTZF vs JNJ: Complete Analysis 2026

PNTZFStock

Trigon Metals Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and maintenance of mines and mineral properties in the African continent. It primarily explores for copper, lead, and silver deposits. The company holds an 80% interest in its flagship project, the Kombat Mine Property, which consists of five mining licenses that covers approximately 1,219 hectares and one prospecting license covering 1,057 hectares located in Northern Namibia. It also holds 100% interest in the Silver Hill Project comprising approximately 16 square kilometers located in the Anti-Atlas region, Morocco. The company was formerly known as Kombat Copper Inc. and changed its name to Trigon Metals Inc. in December 28, 2016. Trigon Metals Inc. was incorporated in 2005 and is headquartered in Toronto, Canada.

Full PNTZF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PNTZF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PNTZF vs SCHDPNTZF vs JEPIPNTZF vs OPNTZF vs KOPNTZF vs MAINPNTZF vs ABBVPNTZF vs MRKPNTZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.